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Background: The presence of regulatory T (Treg) cells in human endometrium is crucial for maintaining
immunological homeostasis within the uterus. For this study we decided to evaluate the subpopulations of Treg
cells in conditions where a disturbance in the immunological equilibrium in ectopic endometrium and decidua has
been observed, such as in cases of ovarian endometriosis (involving local immune cell suppression) and ectopic
pregnancy (involving an increase in local immune system activity). We then compared these findings to what we
observed in the normal eutopic endometrium of women during the secretory phase of the menstrual cycle (with
immune cells under individual control).
Methods: The endometrium tissue samples evaluated in our study were obtained from 47 women during one of
two kinds of laparoscopic procedures. 16 of the women underwent laparoscopies due to Fallopian tube
pregnancies (EP), and 16 due to ovarian endometrioma, while 15 women made up a control group. The presence
of regulatory T cells in these tissue samples was evaluated by FACS.
Results: In our study, the percentages of FOXP3+ cells within the subpopulation of CD4+ T lymphocytes found in
the decidua of the patients treated for Fallopian tube pregnancies were statistically significantly lower than both
those observed in the ovarian endometriosis tissue samples and those found in the secretory eutopic
endometrium samples of the control group.
Conclusion: The disturbance in the immunological equilibrium observed in ectopic endometrium and decidua
would seem to be related to the alteration in the Treg cell population that occurs in these ectopic tissues.
Background
During the normal menstrual cycle the endometrium
within the uterus is widely infiltrated by immune cells
[1-3]. The specific activities of these immune cells are cru-
cial for the proper course of such reproductive processes
as menstruation and implantation. The suppressive profile
of the endometrium is what enables the respective activ-
ities of these infiltrating immune cells. This suppressive
phenomenon of the endometrium is a result both of the
ability of endometrial cells to suppress immune cells and
of the infiltration of the endometrium by such immune
regulatory cells as regulatory T (Treg) cells or suppressive
macrophages (B7H4) [4-6]. In some cases, however, the
endometrium, which constitutes an active form of immu-
noregulatory tissue, is located outside the uterus. In other
cases, as in ectopic pregnancy (e.g., within the Fallopian
tube), the trophoblast cells may be located outside the
uterus, even though the infiltrating trophoblast cells within
the tubal wall are linked to the decidualization of epithelial
and stromal cells. In cases of ovarian endometriosis and
of ectopic pregnancy, mononuclear immune cells are
recruited to the microenvironment of ectopic lesions; after
this Treg cells infiltrate the tissue [7,8].
Treg cells are crucial for the tolerance and prevention
of autoimmunity and have been described as pivotal both
for the survival of allogeneic organ grafts and for the
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any medium, provided the original work is properly cited.evasion of immune surveillance by fetal cells within the
uterus [4-13]. Moreover, it has been observed that the
number of Treg cells in the peripheral blood not only
increases in women during pregnancy but also that their
level of infiltration within the endometrium and decidua
becomes elevated [11]. While Tilburgs et al. have shown
that fetus-specific Treg cells are recruited to the decidua
from the periphery [14], Arruvito et al. have demon-
strated that the changes that take place in the Treg cell
population in the peripheral blood over the different
menstrual cycle phases are crucial for the proper course
of reproductive processes. More specifically, the authors
of the latter study found that the deregulation of the fre-
quency of Treg cells in women with recurrent sponta-
neous abortion (RSA) may contribute to reproductive
failure [15]. Recently, Schumacher et al. have shown that
Treg cell attraction to decidua is associated with the high
HCG concentration that occurs during intrauterine preg-
nancy development [16]. By contrast, the Treg cell con-
centration within the decidua derived from women with
ectopic pregnancy or who suffer from spontaneous abor-
tion is lower because the concentration level of beta
HCG is lower in such conditions than it is in normal
pregnancy [16]. Moreover, the infiltration level of Treg
cells within decidua is decreased in patients suffering
from spontaneous abortion compared with the level of
infiltration found in the decidua of those undergoing
induced abortions [9], and spontaneous abortion is
strongly associated with an increase in the activity of the
maternal immune system [17-19]. Furthermore, it has
been shown that the rupture of the tubal wall is a result
not only of trophoblast cell infiltration, but more impor-
tantly of the accumulation of immune cytotoxic cells
within the ectopic ovum microenvironment [6]. In con-
trast to the situation with ectopic decidua in the Fallo-
pian tube, local suppression of immune cytotoxic cells
has been observed within ectopic endometrium (such as
ovarian endometrioma) during the development of endo-
metriosis [20]. Recently, Berbic et al. have demonstrated
t h ep r e s e n c eo fT r e gc e l l sw i t h i nb o t ht h ee c t o p i ca n d
eutopic endometrium of women suffering from perito-
neal endometriosis. They showed that the FOXP3 expres-
sion within the eutopic endometrium derived from
women with peritoneal endometriosis differs from that
observed in healthy women [21]. An alteration in Treg
lymphocyte infiltration generally disrupts the immunolo-
gical equilibrium. Since the potential role of Treg cells in
maintaining homeostasis in ectopic endometrium and
decidua has not been precisely established in the litera-
ture, from a clinical standpoint, both endometriosis and
ectopic pregnancy constitute unresolved problems.
For this reason, we have chosen the specific type of ecto-
pic endometrium and decidua found at the beginning
of decidualization as a research model in order to
demonstrate the potential role of Treg cells in the devel-
opment of the suppressive profile of the endometrium.
Thus to reiterate, the aim of our present study has been




The endometrium tissue samples evaluated in our study
were obtained from 47 women during one of two kinds
of surgical procedures. 16 of the women underwent
laparoscopic procedures because of unruptured Fallo-
pian tube pregnancies (EP group, mean age 30.7 (± 6.1)
years) and 16 because of ovarian endometrioma, (OE
group, mean age 32.3 ± 5.2) while 15 (constituting the
control group, mean age 35.5 ± 8.1) underwent curet-
tage as an additional procedure during uterine cervix
biopsy on account of a diagnosis of cervical intraepithe-
lial neoplasia or CIN (it should be noted that the biopsy
of the endometrium was an additional procedure for
which the patient’s consent was obtained).
The ectopic endometrium tissue samples were derived
from the women who underwent laparoscopy due to
ovarian endometrioma while the ectopic decidua sam-
ples were derived from those patients who underwent
the procedure because of ectopic pregnancy. Meanwhile,
the eutopic endometrium tissue samples were derived
from the patients on whom curettage was performed.
The patients included in the study were treated between
January 2007 and June 2010 in the Department of Gyne-
cology and Oncology at the Jagiellonian University,
Krakow, Poland. The patients referred to the control
g r o u pw e r er a n d o m l ys e l e c t e df r o mt h eg r o u pw h oh a d
curettage following uterine cervix biopsy because they
were diagnosed with cervical intraepithelial neoplasia.
The patients from the control group were not found to
have any other pathological lesions within the reproduc-
tive tract and had normal, regular menstrual periods.
Patients with intrauterine infections (as confirmed by
histopathological examination) were excluded from the
study. Patients with concomitant systemic diseases, dis-
eases of the thyroid gland, diabetes or hypertension, or
the presence of any other lesions as detected by gyneco-
logical, ultrasound, cytology, or colposcopy examinations
were also excluded. Furthermore, none of the patients
included in our study received any hormonal treatment.
The tissue samples were then independently evaluated
using routinely stained (hematoxylin and eosin) slides
prepared from paraffin-embedded tissue material,
enabling accurate diagnosis: the presence of ectopic preg-
nancy or ovarian endometrioma was confirmed in each
of the patients. All of the patients were then classified
into subgroups according to the particular menstrual
cycle phase as determined by the histopathological
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and the results of clinical examination together with an
assessment of the levels of progesterone, estradiol, and
follicle-stimulating hormone (FSH) in the blood sera.
(Responsible OE group- 8 patients during proliferative
cycle phase FSH mlU/ml 5.62 (± 2.4) mlU/ml; estradiol
140.1 (± 34.2) pg/ml; progesterone 0.87 (± 1.9) ng/ml;
OE group-8 patients during secretory cycle phases FSH
6.5 (± 4.1) mlU/ml; estradiol 159.3 (± 66.3) pg/ml; pro-
gesterone 6.4 (± 3.2) ng/ml; Control group FSH 8.2
(± 5.13) mlU/ml; estradiol 131.4 (± 53.2) pg/ml, proges-
terone 7.56 (± 2.1) ng/ml.).
The patient’s consent was obtained in each case. Prior
to the present study we also obtained the approval of
the Jagiellonian University Ethical Committee for our
research program (DK/KB/CM/0031/447/2010, KBET/
135/B/2007).
Decidual mononuclear cell isolation
The decidua and endometrium samples were cut into
small fragments and disintegrated by being smashed
through a 40 μm cell-strainer. The realized cells were
then spun down and the resulting pellet was subjected
to ammonium chloride lysis in order to get rid of any
contaminating red blood cells. Following lysis, the cells
were washed in PBS. They were then re-suspended in
PBS, counted, and used either immediately for staining
or frozen for future analysis (cells were frozen in a med-
ium consisting of10% DMSO, 5% albumin, and 85% of a
cell culture medium).
Flow cytometry
The cell phenotype was analyzed with the panel of
mAb-CD4 FITC, CD25 APC, and FOXP3 PE (Pharmin-
g e n ) .B r i e f l ys t a t e d ,t ot h e1×1 0
6 cells suspended in
60 μl of staining buffer (PBS, 2% FBS) 20 μl of each
mAb (CD4, CD25) was added. Next the cells were incu-
bated in the dark for 30 min at 4°C. After incubation
the cells were washed twice in PBS and were permeabi-
lized with FoxP3 permeabilization buffer (Becton Dick-
inson; USA) for 10 min at room temperature in the
dark. Following this, they were stained with anti-FOXP3
antibodies for 30 min at 4°C in the dark. The stained
cells were then washed and collected using the FACSC
anto-cytometer (Becton Dickinson; USA), and finally
were analyzed with FACS Diva software (Becton Dickin-
son; USA). Each time 3 × 10
4 events were saved for ana-
lysis. Logical gates were used to analyze particular
populations of cells. The cells were gated first according
to SSC and CD4FITC parameters (gate P1). After this,
the cells from gate P1 were analyzed according to
CD25PE and CD4FITC parameters, and gate P2 was
established on double positive CD4FITC CD25PE cells.
The double positive cells from gate P2 were analyzed
for the presence of FoxP3 antigen. The gate FoxP3+ was
set on cells which had stained positively with FoxP3
APC antibodies (Figure 1).
Statistical analysis
The statistical significance of the recorded differences
among the groups was determined by the Kruskal-Wallis
analysis of variance (ANOVA). All statistical analyses
were carried out with the Statistica 8.0 software program
(StatSoft Inc., Tulsa, OK, USA). A p value < 0.05 was
considered indicative of statistical significance.
Results
CD25+CD4+FOXP3+ T cells were found in all the
examined endometriosis tissue samples. These same
cells were observed in 72% of the eutopic endometrium
tissue samples but were present in only 29% of the tis-
sue samples taken from patients who had ectopic preg-
nancies (Figure 1).
We did not observe any differences over the course of
the menstrual cycle in the percentage of FOXP3+ positive
cells within the subpopulation of CD4+T lymphocytes in
ectopic endometrium in the tissue samples from the
group of patients with ovarian endometriosis. The med-
ian for OE during the proliferative and secretory cycle
phases were 8.5 (16.7) and 6.3 (5.9) respectively.
The percentage of FOXP3+ cells within the subpopu-
lation of CD4+ lymphocytes was statistically significantly
higher in the tissue samples from the patients with
endometriosis as compared with the percentage found
in the tissue samples from the patients who had devel-
oped ectopic pregnancies. Likewise, the percentage of
FOXP3+ cells within the subpopulation of CD4+ lym-
phocytes was higher than in the endometrium from the
control group, but these differences were not statistically
significant. The percentages of these cells observed in
the endometrium from the control group were, however,
statistically significantly higher than those found in the
ectopic deciduas (Figure 2).
Similar results were obtained from analysing FOXP3
positive cells within the subpopulation of CD4+CD25+
lymphocytes (Figure 3).
Discussion
In our study, the percentages of FOXP3+ cells in the
subpopulation of CD4+ T lymphocytes found in the
decidua of the patients treated for Fallopian tube preg-
nancy were statistically significantly lower than both
those observed in the ovarian endometriosis samples
and those found in the secretory eutopic endometrium
of the control group.
Single statements derived from the literature on the
subject indicate that Treg lymphocytes are present
within ovarian endometrial tissue [8,21]. Furthermore, it
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positive lymphocytes found within the subpopulation of
T cells in the peripheral blood of women suffering from
ovarian endometriosis does not differ from that
observed in healthy women [8]. Berbic et al. previously
demonstrated the presence of Treg cells within perito-
neal ectopic endometrium [21]. In that study the
authors demonstrated that there was an alteration in the
FOXP3 expression within the eutopic endometrium that
was derived from women suffering from peritoneal
endometriosis during the secretory cycle phases when
compared to what was observed in the tissue taken
from healthy women [21]. For fertile women the signifi-
cant decrease in the Treg cell population in the periph-
eral blood typically occurs just after ovulation [15]. By
contrast, the women suffering from recurrent sponta-
neous abortion (RSA) were characterized by an absence
of fluctuation in the number of Treg cells [15]. The
increase in the number of Treg cells depends upon
estrogen levels [22], and estrogens are also responsible
for the increase in the immune suppressive potential of
these cells [22]. Estrogen levels generally seem to be
linked with a decrease in TH1 response [22]. Further-
more, a local increase in estrogen levels is characteristic
of patients with ovarian endometrioma lesions. In our
study the percentages of FOXP3+ cells in the subpopu-
lation of CD4+ T lymphocytes found in eutopic endo-
metrium were slightly lower than those found in ovarian
endometrioma tissue. Additionally, no differences in the
percentage of Treg cells within the T lymphocyte subpo-
pulation were observed over the course of the menstrual
cycle in the ovarian endometriosis tissue samples. Most
likely, the absence of Treg cell fluctuation can be linked
to an immune defect arising with the development of
endometriosis. Although in 95% of cases the endome-
trial cells migrate along with retrograde menstruation
from the endometrial cavity to the peritoneal cavity,
only 15% of them actually survive in ectopic localization
despite the host immune system response [23]. Since
they are able to regulate the activity of immune cells,
Figure 1 Treg cell gating strategy. The characterization of the subpopulation of Treg cells (CD4+CD25+FOXP3+) within the subpopulation of
T lymphocytes in eutopic endometrium during the secretory cycle phases (E), ovarian endometriosis (OE), and Fallopian tube pregnancy (EP).
Left panel shows the gating strategy for CD4-positive cells (P1). Middle panel is used to set the gate on double positive CD4
+CD25
+ cells (P2).
On the right panel the histogram representing FoxP3 staining is shown (FoxP3
+).
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immunomodulatory activity of endometrial cells is cru-
cial for the proper course of reproductive processes.
Under normal physiological conditions the intensity of
the immune suppressive activity of the endometrium
depends on the menstrual cycle phase and differs signifi-
cantly between the proliferative and secretory phases (as
has been observed by Arruvito et al. in a study on the
percentage of Treg cells in the late proliferative and
early secretory cycle phases [15] or in different studies
concerning the expression of the factors responsible for
immune cell suppression, such as RCAS1 expression
within endometrial cells) [24]. In patients with endome-
triosis, however, the suppressive activity of the endome-
trium does not fluctuate. In our previous studies we
have demonstrated that both the expression of RCAS1
and HLA-G in ovarian endometriosis and its concentra-
tion in the peripheral blood does not differ between the
proliferative and secretory cycle phases [25,26]. Both
protein RCAS1 and HLA-G are important immunosup-
pressive factors [27-30]. The suppressive profile of the
endometrium therefore depends not only on the absence
of physiological changes–as has been observed from the
Treg cell population–but also on the over-expression of
suppressive factors within ectopic endometrium. For
example, the ovarian endometriosis tissue samples were
characterized by an over-expression of mRNA for
FOXP3 in comparison to normal endometrial tissue [8].
Additionally, women experiencing primary unexplained
infertility have significantly lower FOXP 3 expression
within the endometrium than do fertile women [31].
These studies thus show how important the proper reg-
ulation of immune cell activities is for maintaining
homeostasis during pregnancy. Sasaki et al. have
reported that about 7% of CD4+ cells in the decidua
derived from patients suffering spontaneous abortion
are CD4+CD25
bright cells and that this percentage is
lower than in the tissue of women experiencing normal
pregnancies [9]. Furthermore, Shansham et al. have
shown that patients suffering unexplained spontaneous
abortion were typified by a smaller proportion of CD4
+CD25+FOXP3+ lymphocytes within decidua than
women experiencing normal pregnancies. Recently,
Arruvito et al have demonstrated that the Treg lym-
phoctes of women suffering RSA typically exhibit lower
than normal suppressive activity [32]. Thus the decrease
in the level of Treg cell infiltration within decidua may
result in an increase in both cytotoxic T lymphocyte
and NK cell activity. During pregnancy Treg cells are
recruited to the decidua [10], but the percentage of
Treg cells in both the decidua and the peripheral blood
increases only until spontaneous labor begins [14].
When recruited to the endometrium, Treg cells are
directly able to suppress the immune response to both
fetus-specific and fetus non-specific antigens [14,33].
The beginning of spontaneous labor, however, is asso-
ciated with a decrease in the percentage of Treg cells
within decidua along with a subsequent increase in the
immune response [34-37], as has also been observed
during spontaneous abortion [17]. The activity of
immune cells within the uterus is precisely controlled
Figure 2 The changes in the percentage of FOXP3+ cells within
the subpopulation of CD4+ lymphocytes. The comparison of the
percentages of FOXP3+ cells within the subpopulation of CD4+
lymphocytes in the ectopic endometrium (OE) tissue samples
derived from patients with ovarian endometriosis and in ectopic
decidua (EP) derived from patients with Fallopian tube pregnancy
with the percentages found in the eutopic endometrium samples
derived from patients during the secretory cycle phases (E). The
data is presented as a median ± IQR (Intraquartile Range).
Figure 3 The changes in the percentage of FOXP3+ cells within
the subpopulation of CD4+CD25+ lymphocytes. The comparison
of the percentages of FOXP3+ cells within the subpopulation of
CD4+CD25+ lymphocytes in the ectopic endometrium (OE) tissue
samples derived from patients with ovarian endometriosis and in
ectopic decidua (EP) derived from patients with Fallopian tube
pregnancy with the percentages found in the eutopic endometrium
samples derived from patients during the secretory cycle phases (E).
The data is presented as a median ± IQR (Intraquartile Range).
Basta et al. Reproductive Biology and Endocrinology 2010, 8:116
http://www.rbej.com/content/8/1/116
Page 5 of 7by many factors, and the appearance of such pathology
as preeclampsia, abortion, placental abruption, and
retained placental tissue results from a disturbance in
the regulation of maternal immune cells [38-40]. Just
such a situation has also been observed during the
development of ectopic Fallopian tube pregnancy where
the tubal rupture is seen as a consequence of the
increase in maternal immune cell activity [6,41]. In our
previous study we have demonstrated that the develop-
ment of Fallopian tube pregnancy is related both to the
accumulation of cytotoxic immune cells and NK cells
within ectopic decidua and to a continued increase in
the activity of these cells within the tubal wall [6,41]. In
our current study, however, we observed that the Treg
cell accumulation within the tubal wall was not as dense
as it was within the eutopic endometrium during the
secretory cycle phase. This is not unlike what occurs in
eutopic endometrium with Arias Stella reaction where
the Treg cell population decreases in comparison to that
of eutopic endometrium during the secretory cycle
phases [42]. The decrease in the accumulation of Treg
cells in ectopic decidua within the Fallopian tube wall
observed both in the Schumacher et al. [16] study and
in our current one would therefore seem to be asso-
ciated with an increase in the activity of the immune
cells infiltrating these tissues that leads finally to tubal
rupture. This contrasts with the conditions linked to
ectopic endometrium; ovarian endometrioma develop-
ment, for example, is associated with an immune defect.
This observation would seem to accord with our own
results showing that the percentage of the Treg cells
within the overall cell population was the highest in the
ovarian endometrioma tissue samples.
The proper balance between immune cell activity and
the intensity of the suppressive profile of the endome-
trium or decidua is what enables the proper course of
physiological reproductive processes. The correct bal-
ance is a result of the accumulation of Treg lymphocytes
within the endometrium and decidua respectively. Such
processes as the development of ectopic pregnancy and
ovarian endometrioma are associated with a disturbance
in the suppressive profile of the endometrium resulting
from the alteration in the Treg cell population.
Conclusion
The disturbance in the immunological equilibrium
observed in ectopic endometrium and decidua is asso-
ciated with the alteration in the Treg cell population
that occurs in these ectopic tissues.
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